UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Plasma metabolome analysis of patients with major depressive disorder

Psychiatry and clinical neurosciences, 2018-05, Vol.72 (5), p.349-361

2018

Link zum Volltext

Verfügbarkeit prüfen

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Journal of leukocyte biology, 2007-12, Vol.82 (6), p.1382-1389

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis

Cell metabolism, 2019-06, Vol.29 (6), p.1320-1333.e8

2019

Link zum Volltext

Verfügbarkeit prüfen

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

PPAR Research, 2009-01, Vol.2009 (1), p.952734-952734

2009

Link zum Volltext

Verfügbarkeit prüfen

Association of a Novel Point Mutation (C159G) of the CTLA4 Gene With Type 1 Diabetes in West Africans but not in Chinese

Diabetes (New York, N.Y.), 2001-09, Vol.50 (9), p.2169-2171

2001

Link zum Volltext

Verfügbarkeit prüfen

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid [omega] -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

PPAR research, 2009-01, Vol.2009

2009

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoids and Liver Disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis

American journal of physiology: Gastrointestinal and liver physiology, 2008, Vol.57 (5)

2008

Link zum Volltext

Verfügbarkeit prüfen

SUN-LB082 Sexual Dimorphism of Phosphoethanolamine in HPA-Axis Response to LXR Agonist 25-Hydroxycholesterol: Neuroendocrine Implications for Major Depressive Disorder

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

SUN-LB081 LXR Agonist 25-Hydroxycholesterol Modulates Plasma, Adrenal, and Hypothalamic Phosphoethanolamine Levels: Neuroendocrine Implications for HPA-Axis in Major Depressive Disorder

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Dietary Linoleic Acid Elevates Endogenous Endocannabinoids (2‐AG and Anandamide) and Induces Obesity

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Breast Cancer among Japanese Women: A Case-Control Study in Ibaraki, Japan

Breast cancer (Tokyo, Japan), 1998-10, Vol.5 (4), p.351-358

1998

Link zum Volltext

Verfügbarkeit prüfen

Should peripheral CB 1 cannabinoid receptors be selectively targeted for therapeutic gain?

Trends in pharmacological sciences (Regular ed.), 2009, Vol.30 (1), p.1-7

2009

Link zum Volltext

Verfügbarkeit prüfen

Opinion: Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Trends in pharmacological sciences (Regular ed.), 2009-01, Vol.30 (1), p.1-7

2009

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-g

The Journal of biological chemistry, 2010-06, Vol.285 (25), p.19002-19011

2010

Link zum Volltext

Verfügbarkeit prüfen

Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

European journal of endocrinology, 2001-06, Vol.144 (6), p.639

2001

Link zum Volltext

Verfügbarkeit prüfen

Timing of menopause, reproductive years, and bone mineral density : A cross-sectional study of postmenopausal Japanese women

American journal of epidemiology, 1998-12, Vol.148 (11), p.1055-1061

1998

Link zum Volltext

Verfügbarkeit prüfen

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

The Journal of clinical investigation, 2010-10, Vol.120 (10), p.3735-3735

2010

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid activation at hepatic CB^sub 1^ receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

The Journal of clinical investigation, 2005-05, Vol.115 (5), p.1298

2005

Link zum Volltext

Verfügbarkeit prüfen

Hepatic CB^sub 1^ receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

The Journal of clinical investigation, 2008-09, Vol.118 (9), p.3160

2008

Link zum Volltext

Verfügbarkeit prüfen

Hepatic [CB.sub.1] receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

The Journal of clinical investigation, 2008-09, Vol.118 (9), p.3160

2008

Link zum Volltext

Verfügbarkeit prüfen

Cell type-dependent pro- and anti-inflammatory role of STAT3 in alcoholic liver injury

Gastroenterology (New York, N.Y. 1943), 2008-01, Vol.134 (4), p.1148-1158

2008

Link zum Volltext

Verfügbarkeit prüfen

Paracrine Activation of Hepatic CB 1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

Cell metabolism, 2008, Vol.7 (3), p.227-235

2008

Link zum Volltext

Verfügbarkeit prüfen

The role of the endocannabinoid system in liver ischemia reperfusion injury

The FASEB journal, 2007, Vol.21 (6), p.A807-A807

2007

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid activation at hepatic CB sub(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

The Journal of clinical investigation, 2005-05, Vol.115 (5), p.1298-1305

2005

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase

American journal of physiology. Heart and circulatory physiology, 2005-08, Vol.58 (2), p.H533-H541

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Biological And Medical Sciences
(5)
Fatty Acids
(4)
Medical Sciences
(4)
Obesity
(4)
Endocrinology & Metabolism
(3)
Female
(3)
Humans
(3)
Insulin Resistance
(3)
Risk Factors
(3)
Aged
(2)
Biomedical Research
(2)
Body Fat
(2)
Bone Density
(2)
Cell Biology
(2)
Enzymes
(2)
Fundamental And Applied Biological Sciences. Psychology
(2)
Liver
(2)
Male
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma metabolome analysis of patients with major depressive disorder

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

Association of a Novel Point Mutation (C159G) of the CTLA4 Gene With Type 1 Diabetes in West Africans but not in Chinese

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid [omega] -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

Endocannabinoids and Liver Disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis

SUN-LB082 Sexual Dimorphism of Phosphoethanolamine in HPA-Axis Response to LXR Agonist 25-Hydroxycholesterol: Neuroendocrine Implications for Major Depressive Disorder

SUN-LB081 LXR Agonist 25-Hydroxycholesterol Modulates Plasma, Adrenal, and Hypothalamic Phosphoethanolamine Levels: Neuroendocrine Implications for HPA-Axis in Major Depressive Disorder

Dietary Linoleic Acid Elevates Endogenous Endocannabinoids (2‐AG and Anandamide) and Induces Obesity

Risk Factors for Breast Cancer among Japanese Women: A Case-Control Study in Ibaraki, Japan

Should peripheral CB 1 cannabinoid receptors be selectively targeted for therapeutic gain?

Opinion: Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-g

Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

Timing of menopause, reproductive years, and bone mineral density : A cross-sectional study of postmenopausal Japanese women

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

Endocannabinoid activation at hepatic CB^sub 1^ receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Hepatic CB^sub 1^ receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

Hepatic [CB.sub.1] receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

Cell type-dependent pro- and anti-inflammatory role of STAT3 in alcoholic liver injury

Paracrine Activation of Hepatic CB 1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

The role of the endocannabinoid system in liver ischemia reperfusion injury

Endocannabinoid activation at hepatic CB sub(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase

Aktive Filter

Suchergebnisse filtern